Leading Lymphedema Text Recognizes Bioimpedance Technology

ImpediMed Limited (ASPX:IPD) announced today that the value of bioimpedance technology for the early detection of lymphedema has been recognized in the latest edition of “Lymphedema Diagnosis and Therapy”. Known to clinicians as the ‘green book’, it is a highly respected standard reference work on lymphology for physicians and lymph drainage therapists.